Company Summary

Foldax is a clinical-stage company that has developed the world’s first synthetic polymer aortic and mitral heart valves. The company is delivering non-thrombogenic heart valves at dramatically lower costs to existing artificial or tissue valves.

Year Founded:  2013

Key Executives:
• Frank Maguire, CEO
• Ken Charhut, Chairman

Location:  Salt Lake City, UT

Website:  https://foldax.com/

Company Status:  Private

Year Invested: 2016

Investment Status:  Current

Board Member:  Jim Demetriades